Published in J Immunol on January 15, 2006
The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages. Blood (2006) 2.40
Effective caspase inhibition blocks neutrophil apoptosis and reveals Mcl-1 as both a regulator and a target of neutrophil caspase activation. PLoS One (2011) 1.08
Regulation of neutrophil survival/apoptosis by Mcl-1. ScientificWorldJournal (2011) 0.99
HBx sensitizes cells to oxidative stress-induced apoptosis by accelerating the loss of Mcl-1 protein via caspase-3 cascade. Mol Cancer (2011) 0.98
Mechanisms regulating neutrophil survival and cell death. Semin Immunopathol (2013) 0.94
Flavones induce neutrophil apoptosis by down-regulation of Mcl-1 via a proteasomal-dependent pathway. FASEB J (2012) 0.93
Hepatitis B virus X protein enhances cisplatin-induced hepatotoxicity via a mechanism involving degradation of Mcl-1. J Virol (2011) 0.91
Modulation of Neutrophil Apoptosis and the Resolution of Inflammation through β2 Integrins. Front Immunol (2013) 0.89
Bax/Mcl-1 balance affects neutrophil survival in intermittent hypoxia and obstructive sleep apnea: effects of p38MAPK and ERK1/2 signaling. J Transl Med (2012) 0.83
GEA 3162, a peroxynitrite donor, induces Bcl-2-sensitive, p53-independent apoptosis in murine bone marrow cells. Biochem Pharmacol (2007) 0.82
Serine 162, an essential residue for the mitochondrial localization, stability and anti-apoptotic function of Mcl-1. PLoS One (2012) 0.82
Targeting neutrophil apoptosis for enhancing the resolution of inflammation. Cells (2013) 0.80
Human GAPDH Is a Target of Aspirin's Primary Metabolite Salicylic Acid and Its Derivatives. PLoS One (2015) 0.78
Insights into the apoptotic death of immune cells in sepsis. J Interferon Cytokine Res (2014) 0.78
Decreased activity and accelerated apoptosis of neutrophils in the presence of natural polyphenols. Interdiscip Toxicol (2012) 0.77
Necrostatin-1 enhances the resolution of inflammation by specifically inducing neutrophil apoptosis. Oncotarget (2016) 0.76
Staurosporine resistance in inflammatory neutrophils is associated with the inhibition of caspase- and proteasome-mediated Mcl-1 degradation. J Leukoc Biol (2015) 0.76
Toll-like receptor 9 signaling delays neutrophil apoptosis by increasing transcription of Mcl-1. PLoS One (2014) 0.75
Mcl-1; the molecular regulation of protein function. FEBS Lett (2010) 2.71
Neutrophil function in inflammation and inflammatory diseases. Rheumatology (Oxford) (2010) 2.25
The cytoplasm of living cells behaves as a poroelastic material. Nat Mater (2013) 1.80
Granulocyte macrophage colony-stimulating factor signaling and proteasome inhibition delay neutrophil apoptosis by increasing the stability of Mcl-1. J Biol Chem (2004) 1.67
Haemophilus influenzae induces neutrophil necrosis: a role in chronic obstructive pulmonary disease? Am J Respir Cell Mol Biol (2007) 1.63
Neutropenia in patients receiving anti-tumor necrosis factor therapy. Arthritis Care Res (Hoboken) (2010) 1.55
Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis. J Immunol (2007) 1.44
A congenital activating mutant of WASp causes altered plasma membrane topography and adhesion under flow in lymphocytes. Blood (2010) 1.43
Bile acids inhibit Mcl-1 protein turnover via an epidermal growth factor receptor/Raf-1-dependent mechanism. Cancer Res (2002) 1.37
The mitochondrial network of human neutrophils: role in chemotaxis, phagocytosis, respiratory burst activation, and commitment to apoptosis. J Immunol (2003) 1.32
The many faces of interleukin-6: the role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis. Int J Rheumatol (2011) 1.24
Continuous MLL-ENL expression is necessary to establish a "Hox Code" and maintain immortalization of hematopoietic progenitor cells. Cancer Res (2005) 1.18
Phosphorylation of WASp is a key regulator of activity and stability in vivo. Proc Natl Acad Sci U S A (2009) 1.18
Synovial fluid neutrophils transcribe and express class II major histocompatibility complex molecules in rheumatoid arthritis. Arthritis Rheum (2003) 1.12
The dual effects of TNFalpha on neutrophil apoptosis are mediated via differential effects on expression of Mcl-1 and Bfl-1. Blood (2007) 1.10
Anaplasma phagocytophilum reduces neutrophil apoptosis in vivo. Infect Immun (2003) 1.09
Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy. Rheumatology (Oxford) (2011) 1.07
RNA-seq reveals activation of both common and cytokine-specific pathways following neutrophil priming. PLoS One (2013) 1.05
The role of neutrophil apoptosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum (2009) 1.02
Anatomically corresponded regional analysis of cartilage in asymptomatic and osteoarthritic knees by statistical shape modelling of the bone. IEEE Trans Med Imaging (2010) 1.00
Differential role of neutrophil Fcgamma receptor IIIB (CD16) in phagocytosis, bacterial killing, and responses to immune complexes. Arthritis Rheum (2002) 1.00
Neutrophil apoptosis in rheumatoid arthritis is regulated by local oxygen tensions within joints. J Leukoc Biol (2006) 0.97
Microbial mannan inhibits bacterial killing by macrophages: a possible pathogenic mechanism for Crohn's disease. Gastroenterology (2007) 0.96
Regulation of neutrophil apoptosis. Chem Immunol Allergy (2003) 0.93
Magnetic resonance imaging and musculoskeletal ultrasonography detect and characterize covert inflammatory arthropathy in systemic sclerosis patients with arthralgia. Rheumatology (Oxford) (2010) 0.93
Tactical determinants of setting zone in elite men's volleyball. J Sports Sci Med (2012) 0.93
Changes in expression of membrane TNF, NF-{kappa}B activation and neutrophil apoptosis during active and resolved inflammation. Ann Rheum Dis (2010) 0.92
Mutagenesis of p22(phox) histidine 94. A histidine in this position is not required for flavocytochrome b558 function. J Biol Chem (2002) 0.91
Secretion of oncostatin M by neutrophils in rheumatoid arthritis. Arthritis Rheum (2004) 0.91
Working at arthritis. Rheumatology (Oxford) (2011) 0.89
Evidence for the efficacy of complementary and alternative medicines in the management of rheumatoid arthritis: a systematic review. Rheumatology (Oxford) (2011) 0.87
Serine 162, an essential residue for the mitochondrial localization, stability and anti-apoptotic function of Mcl-1. PLoS One (2012) 0.82
Neutrophil-derived reactive oxygen species in SSc. Rheumatology (Oxford) (2012) 0.81
Endothelial activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signalling: a novel target for systemic sclerosis? Ann Rheum Dis (2010) 0.81
Neutrophil gene expression in rheumatoid arthritis. Pathophysiology (2005) 0.80
Stepping into the state of rheumatology in East Africa. Rheumatology (Oxford) (2012) 0.80
Mavrilimumab, a human monoclonal GM-CSF receptor-α antibody for the management of rheumatoid arthritis: a novel approach to therapy. Expert Opin Biol Ther (2012) 0.80
Inhibition of pre-B cell colony-enhancing factor (PBEF/NAMPT/visfatin) decreases the ability of human neutrophils to generate reactive oxidants but does not impair bacterial killing. J Leukoc Biol (2013) 0.78
The protective effect of GM-CSF on serum-induced neutrophil apoptosis in juvenile systemic lupus erythematosus patients. Clin Rheumatol (2014) 0.77
Baseline vWF factor predicts the development of elevated pulmonary artery pressure in systemic sclerosis. Rheumatology (Oxford) (2012) 0.77
Proliferatory defect of invariant population and accumulation of non-invariant CD1d-restricted natural killer T cells in the joints of RA patients. Mod Rheumatol (2013) 0.76
DcR3 mutations in patients with juvenile-onset systemic lupus erythematosus lead to enhanced lymphocyte proliferation. J Rheumatol (2013) 0.75
Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans. J Clin Invest (2017) 0.75
Relative α₁-anti-trypsin deficiency in systemic sclerosis. Rheumatology (Oxford) (2011) 0.75
Killing of Escherichia coli by Crohn's Disease Monocyte-derived Macrophages and Its Enhancement by Hydroxychloroquine and Vitamin D. Inflamm Bowel Dis (2015) 0.75
Cytokine medicines in clinical practice: current issues. Cytokine (2005) 0.75
Treatment of Behçet's syndrome and plasmacytoma in a patient with peripheral blood stem cell transplantation. Leuk Lymphoma (2008) 0.75
Modeling DCE-MRI at low temporal resolution: a case study on rheumatoid arthritis. J Magn Reson Imaging (2013) 0.75
Ghost busting, taking the sheet off the ghost. Mod Rheumatol (2016) 0.75
Ghostbusting-taking the sheet off the ghost. Rheumatology (Oxford) (2016) 0.75
Rheumatology today and in the future. Rheumatology (Oxford) (2011) 0.75
Behcet's syndrome. BMJ (2009) 0.75
Aqueous Nile blue: a simple, versatile and safe reagent for the detection of latent fingermarks. Chem Commun (Camb) (2014) 0.75
Musculoskeletal research--opportunities for all? Rheumatology (Oxford) (2012) 0.75
Ghostbusting-Taking the sheet off the ghost. Reumatol Clin (2016) 0.75
50th volume--60 years. A golden year. Rheumatology (Oxford) (2011) 0.75
A hole in the roof. Am J Med (2008) 0.75
Second International Conference on Cytokine Medicines. Expert Opin Biol Ther (2005) 0.75
Therapeutic targeting of cytokines. Cytokine (2006) 0.75
Simultaneous biplanar fluoroscopy for the surgical treatment of slipped capital femoral epiphysis. J Pediatr Orthop (2007) 0.75